Related Experiment Video
Updated: Jan 31, 2026

Clinicopathological Analysis of miRNA Expression in Breast Cancer Tissues by Using miRNA In Situ Hybridization
Published on: June 7, 2016
JARID1B expression and its function in DNA damage repair are tightly regulated by miRNAs in breast cancer
Ivano Mocavini1, Simone Pippa2, Valerio Licursi3
1Centre for Genomic Regulation, Barcelona, Spain.
Abstract:
JARID1B/KDM5B histone demethylase's mRNA is markedly overexpressed in breast cancer tissues and cell lines and the protein has been shown to have a prominent role in cancer cell proliferation and DNA repair. However, the mechanism of its post-transcriptional regulation in cancer cells remains elusive. We performed a computational analysis of transcriptomic data from a set of 103 breast cancer patients, which, along with JARID1B upregulation, showed a strong downregulation of 2 microRNAs (miRNAs), mir-381 and mir-486, potentially targeting its mRNA. We showed that both miRNAs can target JARID1B 3'UTR and reduce luciferase's activity in a complementarity-driven repression assay. Moreover, MCF7 breast cancer cells overexpressing JARID1B showed a strong protein reduction when transfected with mir-486. This protein's decrease is accompanied by accumulation of DNA damage, enhanced radiosensitivity and increase of BRCA1 mRNA, 3 features previously correlated with JARID1B silencing. These results enlighten an important role of a miRNA's circuit in regulating JARID1B's activity and suggest new perspectives for epigenetic therapies.
Insights
JARID1B/KDM5B histone demethylase is overexpressed in breast cancer. Two microRNAs (miRNAs), mir-381 and mir-486, were found to target JARID1B mRNA, potentially offering new epigenetic therapy strategies.
Area of Science:
- Molecular Biology
- Cancer Research
- Epigenetics
Background:
- JARID1B/KDM5B histone demethylase mRNA is overexpressed in breast cancer.
- JARID1B plays a role in cancer cell proliferation and DNA repair.
- The post-transcriptional regulation of JARID1B in cancer remains unclear.
Purpose of the Study:
- To investigate the post-transcriptional regulation of JARID1B in breast cancer.
- To identify microRNAs (miRNAs) that target JARID1B mRNA.
- To explore the therapeutic potential of miRNA-mediated JARID1B regulation.
Main Methods:
- Computational analysis of transcriptomic data from 103 breast cancer patients.
- Luciferase reporter assays to confirm miRNA targeting of JARID1B 3'UTR.
- Transfection of MCF7 breast cancer cells with mir-486 to assess JARID1B protein levels and cellular effects.
Main Results:
- JARID1B upregulation correlated with downregulation of mir-381 and mir-486.
- Both miRNAs directly target JARID1B mRNA's 3'UTR.
- Mir-486 transfection reduced JARID1B protein, induced DNA damage, enhanced radiosensitivity, and increased BRCA1 mRNA.
Conclusions:
- A miRNA circuit involving mir-381 and mir-486 regulates JARID1B activity in breast cancer.
- This miRNA-JARID1B interaction presents potential new avenues for epigenetic therapies.
- Targeting this pathway could offer novel treatment strategies for breast cancer.
Related Concept Videos
Overview of DNA Repair
Chemically...
Overview of DNA Repair
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Base Excision Repair
The first step of...
Nucleotide Excision Repair

